# Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

> **NCT01406431** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 48 (actual)

## Conditions studied

- Hyperlipidemia
- Hypertension

## Interventions

- **DRUG:** Pitavastatin, Valsartan
- **DRUG:** Livalo® fixed combination drug

## Key facts

- **NCT ID:** NCT01406431
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-08
- **Final completion:** 2012-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406431, "Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01406431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*